本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Terns Pharmaceuticals, Inc.

7.02
-0.2300-3.17%
成交量:49.23萬
成交額:352.67萬
市值:6.14億
市盈率:-6.74
高:7.32
開:7.24
低:7.00
收:7.25
52周最高:11.40
52周最低:1.87
股本:8,751.10萬
流通股本:5,715.62萬
量比:0.66
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-1.0419
每股收益(LYR):-1.1175
淨資產收益率:-35.02%
總資產收益率:-23.97%
市淨率:2.01
市盈率(LYR):-6.28

資料載入中...

2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/01/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/10/04

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report
2023/07/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/29

SEC問詢函

Form CORRESP - Correspondence
2023/06/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/15

重要事件披露

Form 8-K - Current report